Nanosonics (OTCMKTS:NNCSF – Get Free Report) is expected to announce its resultson Tuesday, August 25th. Analysts expect the company to post earnings of $0.0171 per share and revenue of $75.7710 million for the quarter.
Nanosonics Price Performance
NNCSF stock opened at $2.30 on Monday. The stock’s 50 day moving average price is $2.36 and its 200 day moving average price is $2.42. Nanosonics has a 1 year low of $2.01 and a 1 year high of $3.06.
About Nanosonics
Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.
The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.
Featured Stories
- Five stocks we like better than Nanosonics
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Nanosonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosonics and related companies with MarketBeat.com's FREE daily email newsletter.
